ORAL VERSUS IM ADMINISTRATION OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER

被引：0
|
作者：
BEEX, L
BURGHOUTS, J
VANTURNHOUT, J
BREED, W
HILLEN, H
HOLDRINET, A
BOETIUS, G
HOOGENDOORN, G
DOESBURG, W
VERHULST, M
MEULENBERG, P
机构：
[1] ST RADBOUD HOSP, DEPT EXPTL & CHEM ENDOCRINOL, 6525 GA NIJMEGEN, NETHERLANDS
[2] CATHOLIC UNIV NIJMEGEN, DEPT STAT CONSULTAT, NIJMEGEN, NETHERLANDS
[3] GROOT ZIEKENGASTHUIS, DEPT MED, SHERTOGENBOSCH, NETHERLANDS
[4] ST CANISIUS WILHELMINA HOSP, NIJMEGEN, NETHERLANDS
[5] ST CATHARINA HOSP, EINDHOVEN, NETHERLANDS
[6] ST IGNATIUS HOSP, BREDA, NETHERLANDS
[7] DIACONESSEN HOSP, BREDA, NETHERLANDS
[8] ST GEERTRUIDEN HOSP, DEVENTER, NETHERLANDS
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1151 / 1156
页数：6
相关论文
共 50 条
  • [1] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    HEDLEY, D
    DALGLEISH, A
    COATES, A
    FOX, R
    RAGHAVAN, D
    TATTERSALL, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03): : 205 - 205
  • [2] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN HEAVILY PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER
    GOSS, PE
    ASHLEY, S
    POWLES, TJ
    COOMBES, RC
    CANCER TREATMENT REPORTS, 1986, 70 (06): : 777 - 779
  • [3] ADVANCED BREAST-CANCER - RESPONSE TO HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE
    HEDLEY, D
    DALGLEISH, A
    RAGHAVAN, D
    TATTERSALL, MHN
    COATES, A
    FOX, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1984, 14 (03): : 251 - 254
  • [4] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED MALE BREAST-CANCER
    PANNUTI, F
    MARTONI, A
    BUSUTTI, L
    GRAMELLINI, M
    PIANA, E
    CANCER TREATMENT REPORTS, 1982, 66 (09): : 1763 - 1765
  • [5] ADRENAL SUPPRESSION BY ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    PRATT, JJ
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (02) : 83 - 86
  • [6] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN - A RANDOMIZED CROSSOVER TRIAL IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    VANVEELEN, H
    WILLEMSE, PHB
    TJABBES, T
    SCHWEITZER, MJH
    SLEIJFER, DT
    CANCER, 1986, 58 (01) : 7 - 13
  • [7] HIGH-DOSE VERSUS LOW-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL
    GALLAGHER, CJ
    MCKINNA, JA
    CAIRNDUFF, F
    SMITH, IE
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 213 - 213
  • [8] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE TREATMENT FOR RECURRENT BREAST-CANCER
    IINO, Y
    TAKEO, T
    SUGAMATA, N
    AOYAGI, H
    TAKAI, Y
    TAKEI, H
    ANDO, T
    KOIBUCHI, Y
    YOKOE, T
    OHWADA, S
    HORIGUCHI, J
    MORISHITA, Y
    ANTICANCER RESEARCH, 1995, 15 (03) : 1061 - 1064
  • [9] PHARMACOCLINICAL DATA ON HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    NAMER, M
    MILANO, G
    KHATER, R
    FRENAY, M
    THYSS, A
    RENEE, N
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (02) : 161 - 163
  • [10] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN COMBINATION WITH VINDESINE IN ADVANCED BREAST-CANCER
    FALKSON, HC
    FALKSON, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (12): : 1511 - 1514
12345